{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T07:56:07Z","timestamp":1781682967660,"version":"3.54.5"},"reference-count":15,"publisher":"Norwegian Medical Association","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"DOI":"10.4045\/tidsskr.19.0390","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T08:48:21Z","timestamp":1582793301000},"source":"Crossref","is-referenced-by-count":0,"title":["A man in his fifties with abdominal pain, itching and weight loss"],"prefix":"10.4045","volume":"140","author":[{"given":"Kristin Hammersb\u00f8en","family":"Bj\u00f8rlykke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Lohne","family":"Eftang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Grzyb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l-Dag","family":"Line","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristoffer","family":"Lassen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen","family":"Jahnsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","published-online":{"date-parts":[[2020,2,10]]},"reference":[{"key":"ref=1","unstructured":"Engjom\u00a0T, Waage\u00a0A, Hoem\u00a0D et al. Kronisk pankreatitt \u2013 utredning og behandling. Tidsskr Nor Legeforen 2018; 138. doi: 10.4045\/tidsskr.17.0341. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=29411568&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.4045%2Ftidsskr.17.0341"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Vikse\u00a0J, H\u00e5land\u00a0S, Norheim\u00a0KB. IgG4-relatert sykdom. Tidsskr Nor Legeforen 2017; 137. doi: 10.4045\/tidsskr.16.1099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=28871762&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.4045%2Ftidsskr.16.1099","DOI":"10.4045\/tidsskr.16.1099"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Razumilava\u00a0N, Gores\u00a0GJ. Cholangiocarcinoma. Lancet 2014; 383: 2168\u201379. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24581682&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2FS0140-6736(13)61903-0","DOI":"10.1016\/S0140-6736(13)61903-0"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Klatskin\u00a0G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med 1965; 38: 241\u201356. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14256720&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2F0002-9343(65)90178-6","DOI":"10.1016\/0002-9343(65)90178-6"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Dumonceau\u00a0JM, Tringali\u00a0A, Blero\u00a0D et al. ESGE Clinical Guideline for biliary stenting. Endoscopy 2012; 44: 277\u201398. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22297801&dopt=Abstract","DOI":"10.1055\/s-0031-1291633"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Kamisawa\u00a0T, Zen\u00a0Y, Pillai\u00a0S et al. IgG4-related disease. Lancet 2015; 385: 1460\u201371. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25481618&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2FS0140-6736(14)60720-0","DOI":"10.1016\/S0140-6736(14)60720-0"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Chari\u00a0ST. Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic's HISORt criteria. J Gastroenterol 2007; 42 (suppl 18): 39\u201341. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17520222&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007%2Fs00535-007-2046-8","DOI":"10.1007\/s00535-007-2046-8"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Boonstra\u00a0K, Culver\u00a0EL, de Buy Wenniger\u00a0LM et al. Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis. Hepatology 2014; 59: 1954\u201363. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24375491&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2Fhep.26977","DOI":"10.1002\/hep.26977"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Doorenspleet \u00a0ME, Hubers \u00a0LM, Culver \u00a0EL et al. Immunoglobulin G4(+) B-cell receptor clones distinguish immunoglobulin G 4-related disease from primary sclerosing cholangitis and biliary\/pancreatic malignancies.  Hepatology  2016; 64: 501\u20137.","DOI":"10.1002\/hep.28568"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Wallace\u00a0ZS, Mattoo\u00a0H, Carruthers\u00a0M et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis 2015; 74: 190\u20135. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24817416&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136%2Fannrheumdis-2014-205233","DOI":"10.1136\/annrheumdis-2014-205233"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Roos\u00a0E, Hubers\u00a0LM, Coelen\u00a0RJS et al. IgG4-associated cholangitis in patients resected for presumed perihilar cholangiocarcinoma: A 30-year tertiary care experience. Am J Gastroenterol 2018; 113: 765\u201372. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=29549357&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038%2Fs41395-018-0036-5","DOI":"10.1038\/s41395-018-0036-5"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Khosroshahi\u00a0A, Wallace\u00a0ZS, Crowe\u00a0JL et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol 2015; 67: 1688\u201399. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25809420&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2Fart.39132","DOI":"10.1002\/art.39132"},{"key":"ref=13","unstructured":"Masamune\u00a0A, Nishimori\u00a0I, Kikuta\u00a0K et al. Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis. Gut 2017; 66: 487\u201394. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=27543430&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136%2Fgutjnl-2016-312049"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Carruthers\u00a0MN, Topazian\u00a0MD, Khosroshahi\u00a0A et al. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis 2015; 74: 1171\u20137. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25667206&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136%2Fannrheumdis-2014-206605","DOI":"10.1136\/annrheumdis-2014-206605"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Majumder\u00a0S, Mohapatra\u00a0S, Lennon\u00a0RJ et al. Rituximab maintenance therapy reduces rate of relapse of pancreaticobiliary immunoglobulin G4-related disease. Clin Gastroenterol Hepatol 2018; 16: 1947\u201353. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=29526692&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.cgh.2018.02.049","DOI":"10.1016\/j.cgh.2018.02.049"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":["En mann i 50-\u00e5rene med magesmerter, kl\u00f8e og vekttap"],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T07:35:35Z","timestamp":1781681735000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2020\/02\/noe-laere-av\/en-mann-i-50-arene-med-magesmerter-kloe-og-vekttap"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,10]]},"references-count":15,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,2,25]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.19.0390","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,10]]}}}